Highlights
C&EN: Silicon insertion methods join skeletal-editing toolbox
06 May 2026Two teams take different approaches to squeeze silicon atoms into molecular scaffolds.
ACS Central Science: Pharm to Table Podcast Duo Bridges the Academia–Industry Divide
29 April 2026The Merck colleagues and cohosts advocate closer collaboration between academic and industry chemists.
New Scientist: We need more radioactive drugs. Can we make them from nuclear waste?
22 April 2026The rise of a new generation of radiotherapies means we will soon need much greater quantities of radioactive atoms. That’s why companies are scrambling to refine them from all manner of radioactive waste.
Science: Whistleblower alleges Finnish startup’s vaunted solid-state battery isn’t what it claims
22 April 2026Donut Lab’s assertions of lightning-fast charging and high energy storage have led to a criminal complaint.
Nature: Fresh claim of making elusive ‘hexagonal’ diamond is the strongest yet
04 March 2026After decades of debate, researchers say that they have found the clearest evidence yet for this rare form of carbon.
TESTIMONIALS
“As an editor and reporter, Mark Peplow is fast, accurate, and versatile. He covers science policy and pure research with equal passion, and his writing combines a scientist’s precision with a journalist’s verve.” Tim Appenzeller
Former Chief Magazine Editor at Nature, now News Editor at Science
"Mark guided me through some of the most challenging stories I've written. These are pieces I might not have attempted were it not for his steady editorial hand." Linda Nordling
Freelance Journalist, South Africa
“Working with Mark is never anything other than a pleasure. He is the kind of editor that writers hope for: able to identify what needs fixing and what doesn’t, bringing to bear a wealth of knowledge, always clear, prompt and easy to talk with. Much of that comes from being a splendid writer himself.”
Philip Ball
Freelance Science Writer
Category Archives: Highlights
Nature: UK graphene inquiry reveals commercial struggles
Concerns about the University of Manchester’s National Graphene Institute reflect a broader decline in industrial research and development.
Posted in Highlights
Comments Off on Nature: UK graphene inquiry reveals commercial struggles
Chemistry World: Shadow of Chernobyl
Taking the long view on the cost of nuclear power.
Posted in Highlights
Comments Off on Chemistry World: Shadow of Chernobyl
The BMJ: The 100 000 Genomes Project
Part research project, part commercial stimulus, this enormous sequencing programme could usher genomic medicine into mainstream use.
Posted in Highlights
Comments Off on The BMJ: The 100 000 Genomes Project
Chemistry World: Family friendly science
The perception that young scientists need to sacrifice family life for a career in research must change.
Posted in Highlights
Comments Off on Chemistry World: Family friendly science
Chemical & Engineering News: Stale beer? There’s an app for that
Brewers could use a smartphone to read a simple colorimetric test for beer freshness.
Posted in Highlights
Comments Off on Chemical & Engineering News: Stale beer? There’s an app for that
Spectrum: My Subterranean Tour of London’s Crossrail
It’s a damp, freezing cold day in January, and I’m at the bottom of a massive hole in the ground …
Posted in Highlights
Comments Off on Spectrum: My Subterranean Tour of London’s Crossrail
Spectrum: The Digital Underground
London’s Crossrail Is a $21 Billion Test of Virtual Modeling.
Posted in Highlights
Comments Off on Spectrum: The Digital Underground
Nature: Liquid metal ‘balloons’ offer room-temperature soldering
Invention could help the microelectronics industry to connect circuit-board components without risking heat damage.
Posted in Highlights
Comments Off on Nature: Liquid metal ‘balloons’ offer room-temperature soldering
Chemical & Engineering News: Tiny enzyme tweak expands substrate palette
Changing just two amino acids transforms a picky aldolase into a cosmopolitan catalyst.
Posted in Highlights
Comments Off on Chemical & Engineering News: Tiny enzyme tweak expands substrate palette
Nature: Synthetic malaria drug meets market resistance
First commercial deployment of synthetic biology for medicine has modest impact.
Posted in Highlights
Comments Off on Nature: Synthetic malaria drug meets market resistance
